Canandaigua National Bank & Trust’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$229K Hold
5,962
0.02% 294
2025
Q1
$231K Sell
5,962
-200
-3% -$7.75K 0.02% 289
2024
Q4
$208K Hold
6,162
0.02% 312
2024
Q3
$252K Hold
6,162
0.02% 294
2024
Q2
$237K Hold
6,162
0.03% 284
2024
Q1
$264K Buy
+6,162
New +$264K 0.04% 234
2020
Q1
$306K Hold
6,467
0.06% 181
2019
Q4
$380K Hold
6,467
0.06% 189
2019
Q3
$345K Buy
6,467
+1,794
+38% +$95.7K 0.06% 198
2019
Q2
$234K Hold
4,673
0.04% 240
2019
Q1
$244K Sell
4,673
-1
-0% -$52 0.05% 239
2018
Q4
$223K Hold
4,674
0.05% 249
2018
Q3
$235K Sell
4,674
-609
-12% -$30.6K 0.04% 282
2018
Q2
$266K Buy
5,283
+90
+2% +$4.53K 0.05% 255
2018
Q1
$254K Sell
5,193
-7,045
-58% -$345K 0.03% 315
2017
Q4
$543K Buy
12,238
+1,560
+15% +$69.2K 0.1% 160
2017
Q3
$542K Buy
10,678
+6,195
+138% +$314K 0.1% 161
2017
Q2
$242K Hold
4,483
0.05% 217
2017
Q1
$235K Sell
4,483
-165
-4% -$8.65K 0.07% 174
2016
Q4
$223K Sell
4,648
-147
-3% -$7.05K 0.07% 176
2016
Q3
$259K Buy
4,795
+180
+4% +$9.72K 0.07% 168
2016
Q2
$250K Hold
4,615
0.07% 167
2016
Q1
$234K Buy
4,615
+280
+6% +$14.2K 0.07% 170
2015
Q4
$219K Sell
4,335
-1,360
-24% -$68.7K 0.07% 182
2015
Q3
$274K Buy
5,695
+317
+6% +$15.3K 0.09% 163
2015
Q2
$280K Buy
5,378
+1,211
+29% +$63K 0.08% 169
2015
Q1
$240K Buy
4,167
+382
+10% +$22K 0.07% 181
2014
Q4
$202K Buy
3,785
+300
+9% +$16K 0.06% 188
2014
Q3
$200K Sell
3,485
-264
-7% -$15.2K 0.07% 181
2014
Q2
$251K Sell
3,749
-560
-13% -$37.5K 0.08% 160
2014
Q1
$288K Buy
4,309
+8
+0.2% +$535 0.1% 150
2013
Q4
$287K Buy
+4,301
New +$287K 0.1% 142